Literature DB >> 10976859

Coffee drinking and serum gamma-glutamyltransferase: an extended study of Self-Defense Officials of Japan.

S Honjo1, S Kono, M P Coleman, K Shinchi, Y Sakurai, I Todoroki, T Umeda, K Wakabayashi, K Imanishi, H Nishikawa, S Ogawa, M Katsurada, K Nakagawa, N Yoshizawa.   

Abstract

PURPOSE: To examine the effect of coffee drinking on serum gamma-glutamyltransferase (GGT) level in relation to alcohol drinking, smoking, and degree of obesity in middle-aged Japanese men.
METHODS: From 1986 to 1994, a total of 7,637 male officials of the Self-Defense Forces of Japan aged 48-59 years received a preretirement health examination. Coffee drinking was ascertained by a self-administered questionnaire, and serum GGT level was measured. After excluding 1,360 men with a possible pathologic condition influencing liver enzyme levels and 182 former alcohol drinkers, effect of coffee drinking on serum GGT was examined by a multiple linear regression model and analysis of variance adjusting for alcohol drinking, smoking, and body mass index (BMI).
RESULTS: The adjusted percentage of difference in serum GGT was -4.3 (95% CI = -5.0; -3.5) per cup of coffee. The inverse coffee-GGT relation was most prominent among men drinking > or = 30 ml of ethanol and smoking > or = 15 cigarettes daily; and positive associations of alcohol and smoking with GGT were attenuated by coffee drinking, more clearly among men with BMI > or = 25.00 kg/m2. Adjusted percentages of difference in serum GGT were -2.6% (p = 0.0003) per cup of brewed coffee, and -5.1% (p = 0.0001) per cup of instant coffee, independently of each other.
CONCLUSIONS: The present study suggests that coffee consumption may weaken GGT-induction by alcohol, and possibly by smoking. These effect modifications by coffee may differ according to the degree of obesity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10976859     DOI: 10.1016/s1047-2797(99)00013-7

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  8 in total

1.  Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010.

Authors:  Qian Xiao; Rashmi Sinha; Barry I Graubard; Neal D Freedman
Journal:  Hepatology       Date:  2014-10-30       Impact factor: 17.425

2.  Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.

Authors:  Masao Omata; Laurentius A Lesmana; Ryosuke Tateishi; Pei-Jer Chen; Shi-Ming Lin; Haruhiko Yoshida; Masatoshi Kudo; Jeong Min Lee; Byung Ihn Choi; Ronnie T P Poon; Shuichiro Shiina; Ann Lii Cheng; Ji-Dong Jia; Shuntaro Obi; Kwang Hyub Han; Wasim Jafri; Pierce Chow; Seng Gee Lim; Yogesh K Chawla; Unggul Budihusodo; Rino A Gani; C Rinaldi Lesmana; Terawan Agus Putranto; Yun Fan Liaw; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2010-03-18       Impact factor: 6.047

3.  Serum gamma-glutamyltransferase is inversely associated with dietary total and coffee-derived polyphenol intakes in apparently healthy Japanese men.

Authors:  Chie Taguchi; Yoshimi Kishimoto; Kazuo Kondo; Kazushige Tohyama; Toshinao Goda
Journal:  Eur J Nutr       Date:  2017-10-07       Impact factor: 5.614

4.  Increased caffeine consumption is associated with reduced hepatic fibrosis.

Authors:  Apurva A Modi; Jordan J Feld; Yoon Park; David E Kleiner; James E Everhart; T Jake Liang; Jay H Hoofnagle
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

Review 5.  I drink for my liver, Doc: emerging evidence that coffee prevents cirrhosis.

Authors:  Jordan J Feld; Élise G Lavoie; Michel Fausther; Jonathan A Dranoff
Journal:  F1000Res       Date:  2015-04-21

6.  Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study.

Authors:  J C Dickson; A D Liese; C Lorenzo; S M Haffner; S M Watkins; S J Hamren; J K Stiles; L E Wagenknecht; A J Hanley
Journal:  BMC Gastroenterol       Date:  2015-07-28       Impact factor: 3.067

7.  Effect of caffeine-containing beverage consumption on serum alanine aminotransferase levels in patients with chronic hepatitis C virus infection: a hospital-based cohort study.

Authors:  Yachiyo Sasaki; Satoko Ohfuji; Wakaba Fukushima; Akihiro Tamori; Masaru Enomoto; Daiki Habu; Shuji Iwai; Sawako Uchida-Kobayashi; Hideki Fujii; Susumu Shiomi; Norifumi Kawada; Yoshio Hirota
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

8.  Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations.

Authors:  Silmara Rodrigues Machado; Edison Roberto Parise; Luciana de Carvalho
Journal:  Braz J Infect Dis       Date:  2013-11-22       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.